New Data Support Preoperative Chemoradiation Regimen for Borderline Resectable Pancreatic Cancer
Should patients get chemotherapy or chemoradiation before surgery? Dr. Matthew Katz provides an update on the Alliance study.
Adaptive Pre-Surgery Therapy for Patients with Localized Pancreatic Cancer
Will a flexible approach to neoadjuvant treatment work better for pancreatic cancer patients with tumors that can be removed surgically?
The Pancreatic Standard of Care is No Longer So Standard
Do you want to understand more about how your doctor chooses your treatments? Learn about the standard of care for pancreatic cancer.
What Caused My Pancreatic Cancer?
Despite no known genetic link, Steven Robinson is the fourth member of his family on his mother's side to get pancreatic cancer.
Tonsil Cancer Follow-up Finds Pancreatic Cancer
Gene Waters was fortunate that a follow-up for tonsil cancer found his pancreatic cancer early. He got a second opinion for his treatment.
Comparing Effectiveness of Chemotherapy Before and After Surgery
Is chemotherapy before and after pancreatic cancer surgery more effective than just chemotherapy after surgery?
A Heart Scan Finds Pancreatic Cancer
Barbara Washburn went for a heart scan because of a family history of heart disease. She never expected the scan to find neuroendocrine pancreatic cancer!
Unexpected Blessings From My Pancreatic Cancer
Kelly Pankratz says she has been graced with unexpected blessings in her pancreatic cancer journey, which includes pancreatectomy surgery.
Shedding More Light On Neoadjuvant Treatment
Dr. Matthew Katz reviews the study that compared neoadjuvant treatment with FOLFIRINOX versus gemcitabine/nab-paclitaxel for resectable pancreatic cancer.
Canadian Study NeoPancONE Focuses on Biomarker Validation
Dr. Jennifer Knox is leading the NeoPancONE trial for a biomarker that indicates which patients will respond better to certain chemotherapy before surgery.